Humacyte Launches $30M Stock and Warrants Offering
Company Announcements

Humacyte Launches $30M Stock and Warrants Offering

Humacyte ( (HUMA) ) has shared an announcement.

Humacyte, Inc. has initiated a registered direct offering of approximately $30.0 million in common stock and warrants to an institutional investor. The offering includes over 5.6 million shares and equal warrants, with an exercise price of $5.28 each. The warrants are immediately exercisable with varying expiration periods. The transaction, facilitated by EF Hutton LLC as the placement agent, is expected to close by October 7, 2024, and is part of a previously declared effective shelf registration. The funds raised will support Humacyte’s mission to develop bioengineered human tissue for medical applications.

Find detailed analytics on HUMA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskHumacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
TipRanks Auto-Generated NewsdeskHumacyte Reports Q3 2024 Results Amid FDA Review
TheFlyHumacyte reports Q3 EPS (33c), consensus (25c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App